4suxxess welcomes you!

Setup. Growth. Restructuring. Turnaround.


At 4suxxess, we offer you a team of business architects dedicated to support your company with services designed to enable you to enhance your competitiveness - whether it’s overcoming barriers to success or developing markets locally and globally.

4suxxess provides experienced executive professionals, with the right skill sets to ensure success in challenging assignments and projects.

PharmaTimes: News RSS

International Clinical Researcher of the Year - Still time to enter (Thu, 18 Jan 2018)
There is still time to fill out the MCQ and submit your essay for the prestigious PharmaTimes International Clinical Researcher of theYear competition - but with less than two weeks to go until entries close, you should start the process now.
>> Read More

Report calls for urgent action on R&D model (Thu, 18 Jan 2018)
“Urgent action” is required to boost the productivity of the UK’s R&D model, which is grappling with “unprecedented pressure”, claims a new report by Medicines Discovery Catapult and the BioIndustry Association.
>> Read More

GPs dealing with ‘unsafe’ work load (Thu, 18 Jan 2018)
GPs in the UK are dealing with an average of 41.5 patient contacts every day, which is 60 percent more than what is deemed safe by peers in Europe, an investigation by Pulse has revealed.
>> Read More

Research backs blanket screening for breast, ovarian cancer mutations (Thu, 18 Jan 2018)
Research led by Queen Mary University of London has concluded that whole-population testing for mutations linked with a higher risk of breast and ovarian cancer is cost-effective.
>> Read More

Cabometyx trial halted early on success in liver cancer (Thu, 18 Jan 2018)
A late-stage trial assessing Ipsen and Exelixis’ Cabometyx in advanced liver cancer has been halted early after a significant improvement in overall survival was observed.
>> Read More